Journals / Turkish Journal of Medical Sciences / 2021 / Cilt: 51 - Sayı: 1

Stereological and histopathological evaluation of the effect of Thymoquinone on peridural fibrosis following laminectomy in rats

Pages
375–381
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: The results of our study indicate that thymoquinone is effective in decreasing peridural fibrosis when applied to a laminectomy model.Key words: Laminectomy, peridural fibrosis, thymoquinone

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background/aim: This study’s aim was to investigate the effects of thymoquinone, which is the essential bioactive component of the volatile oil of Nigella sativa on the peridural fibrosis in rats following laminectomy.
📊
Key Findings & Data:The rats were randomly divided into 2 groups: Sham and Surgery + Thymoquinone.
💡
Conclusion & Impact:Conclusion: The results of our study indicate that thymoquinone is effective in decreasing peridural fibrosis when applied to a laminectomy model.Key words: Laminectomy, peridural fibrosis, thymoquinone
🔬Design:Modeling & Simulation
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Background/aim: This study’s aim was to investigate the effects of thymoquinone, which is the essential bioactive component of the volatile oil of Nigella sativa on the peridural fibrosis in rats following laminectomy. Materials and methods: Twenty female Wistar Albino rats were used in our study. The rats were randomly divided into 2 groups: Sham and Surgery + Thymoquinone. Both groups underwent laminectomy at L1 under general anesthesia. The Sham group was not subjected to any drug application. The 2nd group was treated with intraperitoneal 10-mg/kg thymoquinone once per day for a period of 28 days, following the same surgical procedure. All of the group specimens were sacrificed after 4 weeks, and the laminectomy area was examined in terms of new bone volume, capillary volume, and fibrosis volume using stereological approaches. Results: Statistically significant differences were found between the Sham and Surgery + Thymoquinone groups in terms of new bone volume (P = 0.01), capillary volume (P = 0.01), and fibrosis volume (P < 0.001). It was noted that Thymoquinone caused a significant increase in new bone volume, vascular volume and, a significant decrease in fibrosis volume. Conclusion: The results of our study indicate that thymoquinone is effective in decreasing peridural fibrosis when applied to a laminectomy model.Key words: Laminectomy, peridural fibrosis, thymoquinone

🔖

Cite This Article

TÜRKÖZ, D., ÖNGER, M. E., TÜRKÖZ, A., KURUOĞLU, E. (2022). Stereological and histopathological evaluation of the effect of Thymoquinone on peridural fibrosis following laminectomy in rats. Turkish Journal of Medical Sciences, Cilt: 51 - Sayı: 1, 375–381. https://ajindex.com/articles/609814

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Burton CV. Lumbosacral arachnoiditis. Spine (Phila Pa 1976) 1978; 3 (1): 24-30. doi: 10.1097/00007632-197803000-00006 2. Fiume D, Sherkat S, Callovini GM, Parziale G, Gazzeri G. Treatment of the failed back surgery syndrome due to lumbosacral epidural fibrosis. Acta Neurochirurgica. Supplement 1995; 64: 116-118. doi: 10.1007/978-3-7091-9419-5_25 3. Kazanci A, Gurcan O, Gurcay AG, Onder E, Kazanci B et al. Effects of topical Cova™, Tisseel(R) and Adcon(R) gel application on the development of spinal peridural fibrosis: an experimental study in rats. Turkish Neurosurgery 2017; 27 (6): 962-968. doi: 10.5137/1019-5149.JTN.16809-15.1 4. North RB, Campbell JN, James CS, Conover-Walker MK, Wang H et al. Failed back surgery syndrome: 5-year follow-up in 102 patients undergoing repeated operation. Neurosurgery 1991; 28 (5): 685-690; discussion 690-691. 5. Siqueira EB, Kranzler LI, Dharkar DD. Fibrosis of the dura mater: a cause of “failed back” syndrome. Surgical Neurology 1983; 19 (2): 168-170. doi: 10.1016/0090-3019(83)90418-4 6. Slipman CW, Shin CH, Patel RK, Isaac Z, Huston CW et al. Etiologies of failed back surgery syndrome. Pain Medicine: The Official Journal of the American Academy of Pain Medicine 2002; 3 (3): 200-214. doi: 10.1046/j.1526-4637.2002.02033.x 7. Skaf G, Bouclaous C, Alaraj A, Chamoun R. Clinical outcome of surgical treatment of failed back surgery syndrome. Surgical Neurology 2005; 64 (6): 483-488, discussion 488-489. doi: 10.1016/j.surneu.2005.04.009 8. Hernández Vaquero D, Rubio González A, Romo Contreras I, Amigo Fernández A, Domínguez Gil I. La fibrosis peridural como complicación de la discectomía quirúrgica. Revista Brasileira de Ortopedia 1990; 34: 372-376 (in Brazilian Portuguese). 9. De Tribolet N, Porchet F, Lutz TW, Gratzl O, Brotchi J et al. Clinical assessment of a novel antiadhesion barrier gel: prospective, randomized, multicenter, clinical trial of ADCON-L to inhibit postoperative peridural fibrosis and related symptoms after lumbar discectomy. The American Journal of Orthopedics 1998; 27 (2): 111-120. 10. Cauchoix J, Ficat C, Girard B. Repeat surgery after disc excision. Spine (Phila Pa 1976) 1978; 3 (3): 256-259. doi: 10.1097/00007632-197809000-00011 11. Velagapudi R, El-Bakoush A, Lepiarz I, Ogunrinade F, Olajide OA. AMPK and SIRT1 activation contribute to inhibition of neuroinflammation by thymoquinone in BV2 microglia. Molecular and Cellular Biochemistry 2017; 435 (1-2): 149-162. doi: 10.1007/s11010-017-3064-3 12. Mahm